Large-scale testing (Phase 3)Ended earlyNCT01601483
What this trial is testing
Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration
Who this might be right for
Nonexudative Age Related Macular Degeneration
MacuCLEAR, Inc. 22